Association Study of CRP Gene and Ischemic Stroke in a Chinese Han Population

详细信息    查看全文

• 作者：Chong Shen (1)
  Xiaoyang Sun (2)
  Hairu Wang (1)
  Bing Wang (3)
  Yong Xue (4)
  Yun Li (5)
  Jinfeng Chen (1)
  Yuzhang Jiang (3)
  
• 关键词：C ; reactive protein (CRP) gene ; High ; sensitivity C ; reactive protein ; Ischemic stroke
• 刊名：Journal of Molecular Neuroscience
• 出版年：2013
• 出版时间：March 2013
• 年：2013
• 卷：49
• 期：3
• 页码：559-566
• 全文大小：154KB
• 参考文献：1. Arenillas JF, Alvarez-Sabin J, Molina CA, Chacon P, Montaner J, Rovira A et al (2003) C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 34(10):2463-468 CrossRef
  2. Ben-Assayag E, Shenhar-Tsarfaty S, Bova I, Berliner S, Shopin L, Peretz H et al (2007) Triggered C-reactive protein (CRP) concentrations and the CRP gene ?17A>G polymorphism in acute stroke or transient ischemic attack. Eur J Neurol 14(3):315-20 CrossRef
  3. Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C (2002) World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 106(13):1602-605 CrossRef
  4. Chambless LE, Folsom AR, Davis V, Sharrett R, Heiss G, Sorlie P et al (2002) Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-998. Am J Epidemiol 155(1):38-7 CrossRef
  5. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350(14):1387-397 CrossRef
  6. den Hertog HM, van Rossum JA, van der Worp HB, van Gemert HM, de Jonge R, Koudstaal PJ et al (2009) C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol 256(12):2003-008
  7. den Hertog HM, van den Herik EG, Dippel DW, Koudstaal PJ, de Maat MP (2010) Variation in the C-reactive protein gene is associated with serum levels of CRP in patients with acute ischemic stroke. Cerebrovasc Dis 29(4):372-75 CrossRef
  8. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C et al (2005) Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36(6):1316-329 CrossRef
  9. Dickinson CJ (2003) Strokes and their relationship to hypertension. Curr Opin Nephrol Hypertens 12(1):91-6 CrossRef
  10. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22(9):391-97 CrossRef
  11. Eastern Stroke and Coronary Heart Disease Collaborative Research Group (1998) Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 352(9143):1801-807 CrossRef
  12. Elkind MS, Luna JM, Coffey CS, McClure LA, Liu KM, Spitalnik S et al (2010) The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke. Int J Stroke 5(2):117-25 CrossRef
  13. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF et al (2009) Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302(1):37-8 CrossRef
  14. Fisher M (2004) The ischemic penumbra: identification, evolution and treatment concepts. Cerebrovasc Dis 17(Suppl 1):1- CrossRef
  15. Genest J (2010) C-reactive protein: risk factor, biomarker and/or therapeutic target? Can J Cardiol 26(Suppl A):41A-4A CrossRef
  16. Hajat C, Heuschmann PU, Coshall C, Padayachee S, Chambers J, Rudd AG et al (2010) Incidence of aetiological subtypes of stroke in a multi-ethnic population based study: the South London Stroke Register. J Neurol Neurosurg Psychiatry 82(5):527-33
  17. Khreiss T, Jozsef L, Potempa LA, Filep JG (2004) Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 109(16):2016-022 CrossRef
  18. Lee CC, You NC, Song Y, Hsu YH, Manson J, Nathan L et al (2009) Relation of genetic variation in the gene coding for C-reactive protein with its plasma protein concentrations: findings from the Women’s Health Initiative Observational Cohort. Clin Chem 55(2):351-60 linchem.2008.117176">CrossRef
  19. Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43(1):52-8
  20. Masia M, Bernal E, Padilla S, Graells ML, Jarrin I, Almenar MV et al (2007) The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients. Atherosclerosis 195(1):167-71 CrossRef
  21. McGeer PL, McGeer EG (2001) Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22(6):799-09 CrossRef
  22. Miller DT, Zee RY, Suk Danik J, Kozlowski P, Chasman DI, Lazarus R et al (2005) Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69(Pt 6):623-38 CrossRef
  23. Montaner J, Fernandez-Cadenas I, Molina CA, Ribo M, Huertas R, Rosell A et al (2006) Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke 37(5):1205-210 CrossRef
  24. Paffen E, DeMaat MP (2006) C-reactive protein in atherosclerosis: a causal factor? Cardiovasc Res 71(1):30-9 CrossRef
  25. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499-11 CrossRef
  26. Purroy F, Montaner J, Molina CA, Delgado P, Arenillas JF, Chacon P et al (2007) C-reactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurol Scand 115(1):60-6 CrossRef
  27. Ridker PM, Glynn RJ, Hennekens CH (1998) C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97(20):2007-011 CrossRef
  28. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342(12):836-43 CrossRef
  29. Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340(2):115-26 CrossRef
  30. Sakkinen P, Abbott RD, Curb JD, Rodriguez BL, Yano K, Tracy RP (2002) C-reactive protein and myocardial infarction. J Clin Epidemiol 55(5):445-51 CrossRef
  31. Song IU, Kim JS, Kim YI, Lee KS, Jeong DS, Chung SW (2009) Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population. Cerebrovasc Dis 28(6):545-50 CrossRef
  32. Stoll G, Bendszus M (2006) Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37(7):1923-932 CrossRef
  33. Suk HJ, Ridker PM, Cook NR, Zee RY (2005) Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178(1):139-45 CrossRef
  34. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ et al (2005) C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 112(6):900-05 CrossRef
  35. Wang Q, Ding H, Tang JR, Zhang L, Xu YJ, Yan JT et al (2009a) C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population. Acta Pharmacol Sin 30(3):291-98 CrossRef
  36. Wang L, Lu X, Li Y, Li H, Chen S, Gu D (2009b) Functional analysis of the C-reactive protein (CRP) gene ?17A>G polymorphism associated with coronary heart disease. BMC Med Genet 10:73 CrossRef
  37. Welsh P, Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ (2009) Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovasc Dis 27(3):247-53 CrossRef
  38. Wilson AM, Ryan MC, Boyle AJ (2006) The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol 106(3):291-97 CrossRef
  39. Woollard KJ, Geissmann F (2010) Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 7(2):77-6 CrossRef
  40. Wu S, Li Y, Jin C, Yang P, Li D, Li H et al (2011) Intra-individual variability of high-sensitivity C-reactive protein in Chinese general population. Int J Cardiol 157(1):75-9
  41. Zacho J, Tybjaerg-Hansen A, Nordestgaard BG (2009) C-reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular disease. Scand J Clin Lab Invest 69(4):442-46 CrossRef
  
• 作者单位：Chong Shen (1)
  Xiaoyang Sun (2)
  Hairu Wang (1)
  Bing Wang (3)
  Yong Xue (4)
  Yun Li (5)
  Jinfeng Chen (1)
  Yuzhang Jiang (3)
  
  1. Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, 210029, China
  2. Department of Neurosurgery, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, Jiangsu, 223300, China
  3. Department of Medical Laboratory, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, Jiangsu, 223300, China
  4. Department of Medical Laboratory, Huai’an Third People’s Hospital of Huai’an, Huai’an, Jiangsu, 223300, China
  5. School of Public Health, Hebei United University, Tangshan, 063000, China
  

文摘

High-sensitivity C-reactive protein (hsCRP) was reported as a strong, independent predictor of future myocardial infarction and stroke. It is of importance to illustrate the conformance of CRP genetic variation, increment of plasma hsCRP and cerebral events. A case–control study including 548 patients with acute ischemic stroke and 993 age-matched controls from community-based population was conducted and four tagging SNPs (tagSNPs) were genotyped. Multiple logistic regression was applied to evaluate the association of CRP gene and stroke hsCRP elevation with adjustment for covariates. The results indicated that rs3093059 and rs3091244 presented statistical associations with ischemic stroke. Odds ratios (ORs) (95?% confidence interval [CI]) of additive model, dominant model and minor allele at rs3093059 were 0.697 (0.528-.921), 0.671 (0.487-.923) and 0.811 (0.666-.988), and ORs (95?% CI) of dominant model at rs3091244 was 0.728 (0.536-.988), after adjusting for covariates. But there were no significant differences of genotype or allele frequencies of the four SNPs observed between hypertension (HT) and normal blood pressure (NBP) groups. Further analyses indicated the genetic variations of rs876537 and rs3093059 were positively associated with increased square root transformed hsCRP and hsCRP elevation (??mg/l) in ischemic stroke patients, and rs876537 and rs3091244 were associated with hsCRP elevation in controls as well. Our finding suggests that the CRP genetic polymorphisms were associated with decreased risk of ischemic stroke and elevated plasma hsCRP and further replication study and functional research would be warranted.